Table 5.
Clinical history section in report (CHR) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mention/Specialization | Generalization | Common comorbidity | No mention | SUM | |||||||
Clinical history and indication (CHI) | Mention/Specialization | 51 | 3 | 2 | 1 | 57 | |||||
Ast | 11 | 2 | – | – | 13 | ||||||
Cir | 8 | – | 2 | – | 10 | ||||||
Cro | 5 | – | – | – | 5 | ||||||
HNC | 9 | – | – | 1 | 10 | ||||||
HIV | 7 | – | – | – | 7 | ||||||
nHL | 11 | 1 | – | – | 12 | ||||||
SLE | – | – | – | – | – | ||||||
Generalization | 17 | 5 | 1 | – | 23 | ||||||
Ast | 3 | – | – | – | 3 | ||||||
Cir | – | – | – | – | – | ||||||
Cro | 1 | 1 | 1 | – | 3 | ||||||
HNC | 6 | 2 | – | – | 8 | ||||||
HIV | – | – | – | – | – | ||||||
nHL | 5 | 2 | – | – | 7 | ||||||
SLE | 2 | – | – | – | 2 | ||||||
Common comorbidity | 3 | – | – | 6 | 0 | 9 | |||||
Ast | 1 | – | 1 | – | 2 | ||||||
Cir | 2 | – | 4 | 0 | 6 | ||||||
Cro | – | – | – | – | – | ||||||
HNC | – | – | – | – | – | ||||||
HIV | – | – | – | – | – | ||||||
nHL | – | – | – | – | – | ||||||
SLE | – | – | 1 | – | 1 | ||||||
No mention | 16 | 2 | – | 33 | 51 | ||||||
Ast | 2 | – | – | – | 2 | ||||||
Cir | – | – | – | 4 | 4 | ||||||
Cro | 3 | – | – | 9 | 12 | ||||||
HNC | 1 | 1 | – | – | 2 | ||||||
HIV | 4 | – | – | 9 | 13 | ||||||
nHL | 1 | – | – | – | 1 | ||||||
SLE | 5 | 1 | – | 11 | 17 | ||||||
SUM | 87 | 10 | 9 | 34 | 140 | ||||||
Ast | 17 | 2 | 1 | – | 20 | ||||||
Cir | 10 | – | 6 | 4 | 20 | ||||||
Cro | 9 | 1 | 1 | 9 | 20 | ||||||
HNC | 16 | 3 | – | 1 | 20 | ||||||
HIV | 11 | – | – | 9 | 20 | ||||||
nHL | 17 | 3 | – | – | 20 | ||||||
SLE | 7 | 1 | 1 | 11 | 20 |